Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Zhejiang Shengda Bio-Pharm Co., Ltd.
  6. News
  7. Summary
    603079   CNE100002W43

ZHEJIANG SHENGDA BIO-PHARM CO., LTD.

(603079)
  Report
SummaryChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Zhejiang Shengda Bio-Pharm Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021

08/27/2021 | 08:54am EST

Zhejiang Shengda Bio-Pharm Co., Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 390.135 million compared to CNY 450.438 million a year ago. Operating income was CNY 49.987 million compared to CNY 177.916 million a year ago. Net income was CNY 47.889 million compared to CNY 151.428 million a year ago. Basic earnings per share from continuing operations was CNY 0.28 compared to CNY 0.9 a year ago. Diluted earnings per share from continuing operations was CNY 0.28 compared to CNY 0.86 a year ago.


ę S&P Capital IQ 2021
All news about ZHEJIANG SHENGDA BIO-PHARM CO., LTD.
10/29Zhejiang Shengda Bio-Pharm Co., Ltd. Reports Earnings Results for the Nine Months Ended..
CI
08/27Zhejiang Shengda Bio-Pharm Co., Ltd. Reports Earnings Results for the Half Year Ended J..
CI
04/27Zhejiang Shengda Bio-Pharm Co., Ltd. Reports Earnings Results for the First Quarter End..
CI
04/12Zhejiang Shengda Bio-Pharm Co., Ltd. Reports Earnings Results for the Full Year Ended D..
CI
2020Zhejiang Shengda Bio-Pharm Co., Ltd. Reports Earnings Results for the Nine Months Ended..
CI
2020Certain A Shares of Zhejiang Shengda Bio-Pharm Co., Ltd. are subject to a Lock-Up Agree..
CI
2020Zhejiang Shengda Bio-Pharm Co., Ltd. Reports Earnings Results for the Half Year Ended J..
CI
2020Zhejiang Shengda Bio-Pharm Co., Ltd. Announces Cash Dividend for 2019, Payable on June ..
CI
2020Zhejiang Shengda Bio-Pharm Co., Ltd. Reports Earnings Results for the First Quarter End..
CI
2019Zhejiang Shengda Bio-Pharm Co., Ltd. Reports Earnings Results for the Nine Months Ended..
CI
More news
Financials
Sales 2020 867 M 136 M 136 M
Net income 2020 197 M 31,0 M 31,0 M
Net cash 2020 450 M 70,6 M 70,6 M
P/E ratio 2020 18,5x
Yield 2020 1,62%
Capitalization 2 859 M 448 M 448 M
EV / Sales 2019 8,49x
EV / Sales 2020 3,74x
Nbr of Employees 1 068
Free-Float 40,2%
Chart ZHEJIANG SHENGDA BIO-PHARM CO., LTD.
Duration : Period :
Zhejiang Shengda Bio-Pharm Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ZHEJIANG SHENGDA BIO-PHARM CO., LTD.
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Managers and Directors
Bin Zhou General Manager
Gui Hua Xu Chief Financial Officer
Ai Hong Chairman
Yun Xiu Qiu Chairman-Supervisory Board & Deputy Manager
Wei An Wang Independent Director
Sector and Competitors